PTC
DGX icon

Petrus Trust Company’s Quest Diagnostics DGX Stock Holding History

Petrus Trust Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,981
Closed -$271K – 595
2024
Q2 		$271K Sell
1,981
-2,893
-59% -$396K 0.03% 469
2024
Q1 		$649K Buy
+4,874
New +$632K 0.06% 114

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Petrus Trust Company's DGX Position: Q3 2024 in Review

Petrus Trust Company sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 1,981 shares — an estimated $271K sold.

Petrus Trust Company first reported a position in DGX in Q1 2024 and held it in 2 quarters. The position peaked at $649K in Q1 2024. 846 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • Petrus Trust Company reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Petrus Trust Company sold 1,981 Quest Diagnostics shares in Q3 2024, an estimated $271K.
  • Petrus Trust Company first reported a position in Quest Diagnostics in Q1 2024 and held it in 2 quarters.
  • Petrus Trust Company's Quest Diagnostics position peaked at $649K in Q1 2024.
  • 846 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on Petrus Trust Company's 13F filing for Q3 2024, filed 14 Nov 2024.